Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 3

Çocuklarda ve adolesanlarda atriyumlar arası ilişkilerin Amplatzer cihazı ile kapatılması: sonuçlar, başarısız girişimler ve özel noktalar

Transcatheter closure of interatrial communications with Amplatzer device: results, unfulfilled attempts and special considerations in children and adolescents-Original Investigation

Pages
159–164
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Amplatzer is an effective and safe device for transcatheter closure of ASD especially in pediatric patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We report our clinical experience with the Amplatzer device in transcatheter closure of 80 atrial septal defects (ASD) in children.Methods: Among 99 patients (mean age: 7.2±3.8 years) with ASD selected by transthoracic echocardiography, procedures were performed in 80 patients under general anesthesia with fluoroscopic and transesophageal echocardiographic (TEE) guidance.
📊
Key Findings & Data:The patients were discharged at 24 hours after an evaluation with X-ray, electrocardiography and echocardiography.Results: The mean follow-up period (FUP) was 38±14 months.
💡
Conclusion & Impact:Conclusion: Amplatzer is an effective and safe device for transcatheter closure of ASD especially in pediatric patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We report our clinical experience with the Amplatzer device in transcatheter closure of 80 atrial septal defects (ASD) in children.Methods: Among 99 patients (mean age: 7.2±3.8 years) with ASD selected by transthoracic echocardiography, procedures were performed in 80 patients under general anesthesia with fluoroscopic and transesophageal echocardiographic (TEE) guidance. Optimal device size was selected after stretched balloon sizing of the ASD’s. The patients were discharged at 24 hours after an evaluation with X-ray, electrocardiography and echocardiography.Results: The mean follow-up period (FUP) was 38±14 months. Mean ASD size was 11.5± 3.7 mm at TEE (stretched size: 17.6±3.9 mm). The mean size of the device was 18.6±4.0 mm. Procedure and fluoroscopy time were 52.1±17.8 minutes and 11±4.9 minutes respectively. Immediately after the procedure 35 patients (43.8%) had residual shunts. Trivial shunt remained in only 2 of them (2.5%) after FUP. None of the patients had major complications. Minor and transient rhythm abnormalities were observed in 5 patients and trivial mitral regurgitation was seen in 6 patients. Conclusion: Amplatzer is an effective and safe device for transcatheter closure of ASD especially in pediatric patients.

Özet

Amaç: Çalışmanın amacı, Amplatzer cihazı kullanılarak transkateter yöntemle kapatılmış 80 atriyal septal defekt vakası (ASD) (ortalama yaş: 7.2±3.8 yıl) ile ilişkili klinik deneyimlerimizin sunulmasıdır.Yöntemler: Transtorasik ekokardiyografik çalışma ile seçilmiş 99 hasta arasından seçilen 80 atriyal septal defektli hastada genel anestezi altında transözofajiyal ekokardiyografi ve floroskopi kılavuzluğunda transkateter ASD kapatılması işlemi uygulandı. Optimum cihaz çapı balon ile gerilmiş ASD çapı ölçülerek belirlendi. Hastalar işlemden 24 saat sonra göğüs grafisi, elektrokardiyografi ve ekokardiyografi ile değerlendirildikten sonra taburcu edildiler.Bulgular: Ortalama izlem süresi 38±14 aydı. Transözofajiyal ekokardiyografi ile ölçülen ortalama ASD çapı 11.5± 3.7 mm (gerilmiş çap: 17.6±3.9 mm) idi. Ortalama cihaz çapı 18.6±4.0 mm idi. İşlem ve floroskopi zamanı sırasıyla 52.1±17.8 ve 11±4.9 dakika bulundu. İşlemden hemen sonra 35 hastada (43.8%) rezidüel şant saptanırken, izlem süresi sonrasında sadece 2 (2.5%) hastada eser şant gözlendi. Hastaların hiçbirinde majör bir komplikasyon gözlenmedi. Beş hastada minör ya da geçici ritm anormallikleri, 6 hastada da eser mitral yetmezliği gözlendi. Sonuç: Çocuk ve adolesan hastalarda transkateter ASD kapatılması için Amplatzer etkili ve güvenli bir cihazdır.

🔖

Cite This Article

AYABAKAN, C., BİLGİÇ, A., ÇELİKER, A., ÖZKUTLU, S., KARAGÖZ, T. (2022). Çocuklarda ve adolesanlarda atriyumlar arası ilişkilerin Amplatzer cihazı ile kapatılması: sonuçlar, başarısız girişimler ve özel noktalar. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 3, 159–164. https://ajindex.com/articles/437391

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med 1990; 323: 1645-50
  2. King TD, Mills NL. Secundum atrial septal defects: non-operative closure during cardiac catheterization. JAMA 1976; 235: 2506-9
  3. Rashkind W. Transcatheter treatment of congenital heart disease. Circulation 1983; 67: 711-6
  4. Thanopoulos BD, Laskari CV, Tsaousis GS, et al. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1998; 31: 1110-6
  5. Lock JE, Rome JJ, Davis R, Van Praagh R, Keane JF. Transcatheter closure of atrial septal defects: experimental studies. Circulation 1989; 79: 1091-9
  6. Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Double-umbrella closure of atrial defects: initial clinical applications. Circulation 1990; 82: 751-8
  7. Sideris EB, Sideris SE, Fowlkes JP, et al. Transvenous atrial septal defect occlusion in piglets with a “buttoned” double-disk device. Circulation 1990; 81: 312-8
  8. Sideris EB, Sidreis SE, Thanapoulos BD, Ehly RL, Fowlkes JP. Transvenous atrial septal defect occlusion by the buttoned device. Am J Cardiol 1990; 66: 1524-6
  9. Rao PS, Sideris EB, Hausdorf G, et al. International experience with secundum atrial septal defect occlusion by the buttoned device. Am Heart J 1994; 128: 1022-35
  10. Babic UU, Grujicic S, Popovic Z, et al. Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience. J Interv Cardiol 1991; 4: 283-94
  11. Hausdorf G, Schneider M, Franzbach B, et al. Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children. Heart 1996; 75: 83-8
  12. Das GS, Voss G, Jarvis G, et al. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation 1993; 88: 1754-64
  13. Celiker A, Bilgic A, Ozkutlu S, et al. A late complication with the CardioSeal ASD occluder device and need for surgical revision. Catheter Cardiovasc Interv 2001; 54: 335-8
  14. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004; 43: 310-2
  15. Formigari R, Santoro G, Rosetti L, et al. Comparison of three different atrial septal defect occlusion devices. Am J Cardi